Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
LEXINGTON, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
Healthcare
DeliverHealth and Google Cloud Partner to Bring Industry-Leading AI for Comprehensive and Accurate Clinical Documentation Solutions
MADISON, Wis., Feb. 28, 2025 /PRNewswire/ -- DeliverHealth, the leader in healthcare clinical documentation, is proud to partner with Google Cloud...
hellocare.ai to Implement Virtual Care Solution at AdventHealth to Enhance Patient Experience and Operational Efficiency
CLEARWATER, Fla., Feb. 28, 2025 /PRNewswire/ -- hellocare.ai, a leader in AI-assisted virtual care delivery, is proud to announce its...
IllumiCare Delivers Cost-Saving Insights on Low-Value Care Directly to Providers’ Mobile Devices
BIRMINGHAM, Ala., Feb. 28, 2025 /PRNewswire/ -- IllumiCare is the market leader in "nudging" healthcare providers in their EMR ordering workflow when...
Tennr Welcomes Bruna Dos Santos as Industry Expert to Drive DME Innovation
NEW YORK, Feb. 28, 2025 /PRNewswire/ -- Tennr, the intelligent automation platform for healthcare operations, today announced the appointment of...
Waystar expands authorization automation to address healthcare providers’ top 2025 investment priority
Latest software innovation automates every step of the authorization submission process, reducing time by 70% and dramatically boosting auto-approval rates LEHI,...
Visionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and Biotechnology
TORONTO, Feb. 28, 2025 /PRNewswire/ -- In the context of the global economy's digital transformation, Artificial Intelligence (AI) has emerged...
Roundtrip and Call the Car Partner to Revolutionize Medicaid Transportation for Southern California Members
LOS ANGELES, Feb. 28, 2025 /PRNewswire/ -- Roundtrip, a leading platform for simplifying medical transportation, and Call the Car, a...
Transforming Compliance: How RAAPID’s Purpose-Built AI Technology is Revolutionizing Risk Adjustment Audit Preparation
LOUISVILLE, Ky., Feb. 28, 2025 /PRNewswire/ -- RAAPID, an AI-powered risk adjustment technology leader, will present critical insights on modernizing RADV...
Retrieve Medical, Inc. Emphasizes Proactive Compliance Amidst Upcoding Scrutiny: Our Patent Pending Preprocessor has Multi-billion Dollar Market Potential
BEDMINSTER, N.J., Feb. 28, 2025 /PRNewswire/ -- In light of recent reports regarding investigations into Medicare Advantage billing practices, Retrieve...
NeuralCure AI Partners with Leading Medical Imaging Provider to Enhance AI-Powered Diagnostic Support for Physicians
AI-Driven Insights to Be Integrated with Life Imaging FLA's Full-Body CT Scan Services Through Their Upcoming 200 Location Expansion DENVER...
Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference
WARSAW, Ind., Feb. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of...
ADIA Nutrition Inc. Ignites 2025 with February Breakthroughs, Riding Adia Med’s Profitable January Triumph
Winter Park, Florida--(Newsfile Corp. - February 28, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a pioneer in healthcare innovation...
Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)
Two-year efficacy and safety data analyses from Phase III SUNSHINE and SUNRISE trials of continuous Cosentyx® (secukinumab) treatment in HS...
InflaRx to Showcase Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
JENA, Germany, Feb. 28, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today...
TREMFYA® (guselkumab) receives positive CHMP opinion for treatment of adult patients with moderately to severely active ulcerative colitis
Recommendation based on the findings from the Phase 3 QUASAR programme in ulcerative colitis1 Beerse, Belgium (28 February 2025) –...
Noom Expands into Hormone Replacement Therapy to Support Women’s Health and Well-being
Noom + HRTRx blends Noom’s proven behavior change program with HRT medication to achieve whole-person healthThe new offering builds on...
Safety Shot, Inc. Appoints CORE IR & PR for Investor Relations, Shareholder Communications and Public Relations Services
CORE IR & PR to support strategic communications in conjunction with corporate development and commercial activities SCOTTSDALE, Ariz., Feb. 28,...
CHMP recommends EU approval of Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma
Columvi plus chemotherapy showed a 41% reduction in the risk of death in the pivotal phase III STARGLO study1,2 DLBCL—an...
Johnson & Johnson’s DARZALEX® (daratumumab) subcutaneous-based regimen receives positive CHMP opinion for patients with newly diagnosed multiple myeloma, regardless of transplant eligibility
If approved, daratumumab will be the only anti-CD38 available for all patient types across newly diagnosed multiple myeloma, cementing daratumumab...